Casandra
Casandra Test Code QD10542Version 1 (DRAFT)
Performing Lab
Borrelia miyamotoi Antibodies (IgG, IgM), Immunoassay
Also known as: GLPQ, B. miyamotoi
Clinical Use
Order TestUse
This immunoassay aids in detecting infection with Borrelia miyamotoi by measuring both IgG and IgM antibody responses. As most infected patients may be seronegative in the acute phase, clinical suspicion should prompt collection of a convalescent specimen several weeks later to improve detection.
Special Instructions
Not provided.
Limitations
Seronegative results may occur in early infection; convalescent sampling is recommended in such cases to improve sensitivity.
Test Details
Methodology
Immunoassay
Biomarkers
B. miyamotoi Ab (IgG)
AnalyteIgG
Other • Binary (Detected / Not Detected)
B. miyamotoi Ab (IgM)
AnalyteIgM
Other • Binary (Detected / Not Detected)
Result Turnaround Time
6-8 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
Container
Gold (SST) top tube, plain, gel
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
Similar Tests
Other tests from different labs that may be relevant
Borrelia miyamotoi Detection, PCR, Blood
Mayo Clinic Lab
Borrelia burgdorferi Antibodies, IgG and IgM by Immunoblot
ARUP Laboratories
Babesia microti Antibodies, IgG and IgM
Labcorp
Babesia microti Antibodies, IgG and IgM by IFA
ARUP Laboratories
Babesia microti Antibody, IgM by IFA
ARUP Laboratories
Borrelia burgdorferi Antibody, IgG by Immunoblot
ARUP Laboratories
Lyme IgM and IgG, Whole Cell Sonicate, ELISA, Serum
Mayo Clinic Lab
Babesia microti IgG Antibodies, Serum
Mayo Clinic Lab
Lyme Antibodies, Modified 2-Tier Testing Profile, Serum/Plasma
Labcorp
Lyme Disease Antibody, Immunoblot, Serum
Mayo Clinic Lab